Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report

Primary bone diffuse large B-cell lymphoma (PB-DLBCL) has been rarely reported because of its low incidence. The optimal treatment plan for patients with relapsed/refractory PB-DLBCL remains controversial. In this study, we present a case of a 57-year-old patient with refractory PB-DLBCL to better u...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhiya, Teng, Yue, Wu, Jianqiu, Zhang, Honglu, Peng, Weiwei, Meng, Cheng, Tang, Weiyan, Feng, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810803/
https://www.ncbi.nlm.nih.gov/pubmed/36619626
http://dx.doi.org/10.3389/fmed.2022.989590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810803/
https://www.ncbi.nlm.nih.gov/pubmed/36619626
http://dx.doi.org/10.3389/fmed.2022.989590

Ejemplares similares